Key result
The G894T eNOS polymorphism was significantly associated with ischemic stroke in the Moroccan population (recessive model OR 2.68; 95% CI 1.08-6.70; P<0.05).
Why the study?
Is the G894T eNOS polymorphism associated with an increased risk of ischemic stroke in a Moroccan population?
Case-Control (n=347)
Is the G894T eNOS polymorphism associated with an increased risk of ischemic stroke in a Moroccan population?
Odds Ratio: 2.68 (95% CI 1.08–6.7)
p-value: p=< 0.05
The G894T eNOS polymorphism is significantly associated with ischemic stroke in the Moroccan population, suggesting its potential as a genetic risk marker.
Does not support clinical genetic testing; leaves open validation of G894T eNOS as a stroke risk marker in North Africans.
Nitric oxide plays a major role in the regulation of cerebral blood flow and loss of its function leads to alteration of the vascular relaxation given its central role in the physiology of the vascular system. G894T eNOS polymorphism could have adverse effects on the expression and activity of endothelial nitric oxide synthase, which can result in functional impairment of the endothelium and contribute to the development of ischemic stroke in the different models of transmission. In this study, genotyping with PCR-RFLP and HRM (high resolution melting) methods were conducted on 165 ischemic stroke patients as well as 182 controls. The goal here was to compare genotyping with PCR-RLFP primer sequences of eNOS gene (size < 300 bp) to HRM. Our data suggests a statistically significant association between G894T eNOS polymorphism and ischemic stroke in recessive, dominant and additive models with P < 0.05 and odds ratio of 2.68 (1.08-6.70), 1.78 (1.16-2.73), and 1.71 (1.21-2.43) respectively. In sum, although the sample size is relatively small, it suggests that G894T eNOS polymorphism could be a potentially important genetic marker of ischemic stroke in the Moroccan population. Future studies should be conducted in this direction taking into consideration the functional activity of eNOS.
No takes yet. Share an insight, caveat, or question.
Diakité et al. (2014) conducted a case-control in Ischemic stroke (n=347). G894T eNOS polymorphism vs. Controls was evaluated on Ischemic stroke (OR 2.68, 95% CI 1.08-6.70, p=< 0.05). The G894T eNOS polymorphism was significantly associated with ischemic stroke in the Moroccan population (recessive model OR 2.68; 95% CI 1.08-6.70; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: